Wells Fargo & Company Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target lowered by research analysts at Wells Fargo & Company from $20.00 to $19.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 14.80% from the stock’s previous close.

Several other equities research analysts have also recently issued reports on XRAY. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a report on Friday. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Finally, Morgan Stanley reduced their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $23.58.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $16.55 on Friday. DENTSPLY SIRONA has a one year low of $16.21 and a one year high of $34.91. The business’s fifty day moving average price is $18.83 and its two-hundred day moving average price is $21.50. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market cap of $3.29 billion, a PE ratio of -8.00, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently bought and sold shares of the company. Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA in the third quarter valued at about $27,000. Kennebec Savings Bank bought a new stake in DENTSPLY SIRONA in the third quarter valued at about $35,000. Colonial Trust Co SC bought a new stake in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. Riverview Trust Co bought a new stake in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.